VEGFR2-targeted MBs have been used for ultrasound imaging in mouse models of a wide range of tumor types, including colon cancer [50,51], liver cancer [52], bladder cancer [53], breast cancer [54], and melanoma [55]. This evidence concerns the gene KDR and urinary bladder carcinoma.